Ujvira 100mg Injection
Inclusive of all taxes
Free Express Cold-Chain Delivery
Temperature-controlled dispatch across India within 4 to 24 hours.
Order through WhatsAppFinancial Assistance Available
Contact our oncology support team to check your eligibility for manufacturer patient assistance programs (PAP) for Ujvira 100mg Injection.
About this medicine
Ujvira 100mg Injection (TRASTUZUMAB EMTANSINE)is a prescription oncology medicine. Below is educational product information — follow your doctor's advice for dose and use.
Ujvira 100 mg Injection is a specialised injection used to treat certain types of breast and stomach cancers that produce too much of a protein called HER2. By targeting these specific cancer cells, it helps slow down or stop their growth. This medicine is a key part of targeted cancer therapy prescribed by oncology specialists. Ujvira 100 mg Injection is given as an injection or infusion, typically once every week or every three weeks, depending on your treatment plan. Consistency is vital, so keeping all your scheduled appointments is highly recommended. To support your body during treatment, maintaining a balanced diet, staying well-hydrated, and getting plenty of rest can help manage physical demands. Some people experience mild side effects like chills, fever, or nausea, particularly during or after the first few sessions. However, you must seek immediate medical help if you experience serious symptoms such as shortness of breath, swelling in your legs, or a rapid heartbeat, as these can point to heart or lung complications. Before starting Ujvira 100 mg Injection, inform your doctor if you have a history of heart disease, high blood pressure, or lung disorders. Do not take this medicine if you have had a severe allergic reaction to it or its ingredients in the past. Pregnant women should also avoid this medicine as it can cause harm to an unborn baby. It is important to tell your healthcare provider about all other medicines you take, as some can increase the risk of heart damage when combined with Ujvira 100 mg Injection. Limit or avoid alcohol and smoking to prevent extra strain on your organs. If you are breastfeeding or elderly, talk to your doctor to understand the risks and benefits before starting treatment.
Quick Facts
Generic Name
TRASTUZUMAB EMTANSINE
Dosage Form
Powder
Prescription Status
Doctor's Rx Required
Uses of Ujvira 100mg Injection
Side Effects of Ujvira 100mg Injection
Oncology medicines should be administered strictly under medical supervision. Inform your oncologist immediately if you experience adverse symptoms.
Clinical Safety Advice for Ujvira 100mg Injection
Follow expert clinical guidelines regarding interactions, precautions, and medical conditions when taking Ujvira 100mg Injection.
It is not known whether it is safe to consume alcohol with Ujvira 100mg Injection. Please consult your oncologist.
Ujvira 100mg Injection is unsafe to use during pregnancy as it can cause serious birth defects and fetal harm. Effective contraception must be used during treatment and for a period after the last dose. Please consult your doctor.
Ujvira 100mg Injection is unsafe to use during breastfeeding. It is not known if the drug passes into breastmilk, and it may cause serious harm to a nursing infant.
Ujvira 100mg Injection may cause fatigue, headache, or dizziness. Exercise caution if you feel unwell or tired after your infusion before driving or operating machinery.
Ujvira 100mg Injection is generally considered safe to use in patients with mild kidney disease. However, patients with moderate-to-severe renal impairment require careful medical monitoring. Please consult your doctor.
Ujvira 100mg Injection should be used with caution in patients with liver disease, as it can affect liver function enzymes. Regular liver function monitoring is required during treatment. Please consult your doctor.
Cold-Chain Temperature Protocol
Temperature-controlled cold-chain dispatch for Ujvira 100mg Injection across India, with express delivery in Delhi NCR, Noida, and Ghaziabad.
Temperature Monitoring
Sourced from certified cold-storage warehouses.
Insulated Transit
Dispatched in gel-ice thermal insulated boxes.
Rx Verification
Prescription validated prior to cold dispatch.
Frequently Asked Questions
Clinical Overview: Ujvira 100mg Injection
Ujvira 100mg Injection is a breakthrough targeted therapy created by Zydus Lifesciences specifically for HER2-positive breast cancer. By ingeniously combining a targeted antibody with a strong chemotherapy agent in a single dose, it offers a highly effective and more accessible treatment option for patients who need it most.
How It Works (Mechanism of Action)
Think of Ujvira as a highly precise delivery system. It uses a 'Trojan horse' approach to seek out and attach directly to the HER2 receptors on the surface of breast cancer cells. Once attached, it goes inside the cancer cell and releases a powerful chemotherapy dose right where it's needed. This destroys the tumor from the inside while largely sparing the healthy tissues around it.
Therapeutic & Treatment Context
Oncologists generally prescribe Ujvira for adults dealing with HER2-positive breast cancer that has either spread to other parts of the body (metastatic), or for patients who still have some signs of the disease remaining after their initial pre-surgery treatments.
Important Clinical Information & Precautions
Because Ujvira is a specialized IV infusion, it must only be given by a trained healthcare professional in a clinic or hospital setting. While you are on this treatment, your doctor will keep a close eye on your heart health, liver function, and blood counts to ensure you are tolerating it well. Please note that this medication is not safe to use during pregnancy or while breastfeeding.
Storage & Safe Handling Instructions
This medicine is highly temperature-sensitive. It must be kept refrigerated at a strict 2°C to 8°C. It should never be frozen or shaken, and needs to stay in its original carton to protect it from light until your nurse or doctor prepares your infusion.
Dosage & Administration Guidelines
Your care team will give you Ujvira through an IV drip, usually once every three weeks. Your exact dose is carefully calculated based on your body weight. The very first infusion takes about 90 minutes so your team can monitor your reaction, but future sessions might only take 30 minutes if everything goes smoothly.
Authoritative References & Medical Sources
- FDA Prescribing Information for Trastuzumab EmtansineUS FDAView Source
- NCCN Clinical Practice Guidelines in Oncology: Breast CancerNCCNView Source
Medical information standards
Educational product information for Ujvira 100mg Injection. Not a substitute for advice from your treating doctor or healthcare provider.
- Reviewed by
- Nitin Kumar, D.Pharm (UPPC Reg: 63405)Lead Registered Pharmacist · 11 years clinical experience · Drug licence RLF21DL2025001406, RLF20DL2025001420. See our medical review policy.
- Content dates
- Catalogue copy is re-checked under our editorial standards. Pricing and stock update more often at checkout.
- Business address
- Vyloo Technologies Pvt. Ltd.
10251, F/F, Library Road, Nawab Ganj, Delhi G.P.O., Delhi, North Delhi- 110006, Delhi, IndiaGSTIN 07AAKCV0933E1ZF, 09AAKCV0933E1ZB. More on our drug licence page.
Authoritative references
- CDSCO (India) — Central Drugs Standard Control Organisation — Indian drug regulator
- Ministry of Health & Family Welfare — Government of India health ministry
- WHO Essential Medicines — World Health Organization essential medicines lists
- National Health Portal (India) — Government of India National Health Portal
Have questions about your cancer prescription?
Our licensed oncology pharmacists are available to assist with medicine availability, cold-chain handling, and prescription verification.